Europe Upstream Bioprocessing Market
No. of Pages: 124 | Report Code: BMIRE00030684 | Category: Life Sciences
No. of Pages: 124 | Report Code: BMIRE00030684 | Category: Life Sciences
The Europe upstream bioprocessing market was valued at US$ 2,581.59 million in 2022 and is expected to reach US$ 7,069.78 million by 2030; it is estimated to grow at a CAGR of 13.4% from 2022 to 2030. Outsourcing of Biopharmaceutical Manufacturing Drives Europe Upstream Bioprocessing Market
A large number of contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs) are engaging in bioprocessing activities, which triggers the demand for bioreactors in these facilities. The strategic outsourcing of pharmaceutical manufacturing through bioprocessing allows biopharmaceutical companies to leverage external partners' expertise and advanced capabilities in upstream processes, facilitating access to specialized technologies, process optimization expertise, and scalable manufacturing capacity. By partnering with CDMOs and CMOs, biopharmaceutical firms can efficiently manage manufacturing needs, accommodate fluctuations in production demands, and focus on core research and development activities. Additionally, outsourcing offers cost efficiencies and risk mitigation by leveraging external partners' established infrastructure and regulatory-compliant facilities. Outsourcing the bioprocessing functions allows biopharmaceutical companies to focus on fostering innovation, technological advancements, and overall upstream process expansion. Thus, the outsourcing of biopharmaceutical manufacturing significantly drives the growth of the upstream bioprocessing market.Europe Upstream Bioprocessing Market Overview
The Europe upstream bioprocessing market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. It is expected to register a robust growth rate owing to the availability of government and private funding for research in biologics and pharmaceuticals, leading to the launch of innovative technologies. The region has various organizations and bodies that monitor the practices being carried out in the pharmaceutical industry through conferences and other events. Companies in Europe have been focusing on showcasing their products at various events to be able to strengthen their customer base and collect information regarding developments made by any other players in the region. Thus, research initiatives, innovative products, and events such as conferences benefit the upstream bioprocessing market in Europe.
Europe Upstream Bioprocessing Market Revenue and Forecast to 2030 (US$ Million)
Strategic insights for the Europe Upstream Bioprocessing provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the Europe Upstream Bioprocessing refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
Get more information on this report Europe Upstream Bioprocessing Strategic Insights
Get more information on this report Europe Upstream Bioprocessing Report Scope
Report Attribute
Details
Market size in 2022
US$ 2,581.59 Million
Market Size by 2030
US$ 7,069.78 Million
Global CAGR (2022 - 2030)
13.4%
Historical Data
2020-2021
Forecast period
2023-2030
Segments Covered
By Product Type
By Workflow
By Mode
Regions and Countries Covered
Europe
Market leaders and key company profiles
Get more information on this report Europe Upstream Bioprocessing Regional Insights
Get more information on this report Europe Upstream Bioprocessing Market Segmentation
The Europe upstream bioprocessing market is segmented based on product type, workflow, usage type, mode, and country. Based on product type, the Europe upstream bioprocessing market is segmented into bioreactors/fermenters, cell culture, filters, bags and containers, and others. The bioreactors/fermenters services held the largest market share in 2022.
Based on workflow, the Europe upstream bioprocessing market is categorized into media preparation, cell culture, and cell separation. The cell separation held the largest market share in 2022.
Based on usage type, the Europe upstream bioprocessing market is bifurcated into single-use and multi-use. The single-use held a larger market share in 2022
Based on mode, the Europe upstream bioprocessing market is bifurcated into In-house and outsourced. The In-house held a larger market share in 2022.
Based on country, the Europe upstream bioprocessing market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe upstream bioprocessing market share in 2022.
Thermo Fisher Scientific Inc, Esco Micro Pte Ltd, Cellexus International Ltd, Sartorius AG, Getinge AB, Merck KGaA, Corning Inc, and Entegris Inc are some of the leading companies operating in the Europe upstream bioprocessing market.
1. Thermo Fisher Scientific Inc
2. Esco Micro Pte Ltd
3. Cellexus International Ltd
4. Sartorius AG
5. Getinge AB
6. Merck KGaA
7. Corning Inc
8. Entegris Inc
The Europe Upstream Bioprocessing Market is valued at US$ 2,581.59 Million in 2022, it is projected to reach US$ 7,069.78 Million by 2030.
As per our report Europe Upstream Bioprocessing Market, the market size is valued at US$ 2,581.59 Million in 2022, projecting it to reach US$ 7,069.78 Million by 2030. This translates to a CAGR of approximately 13.4% during the forecast period.
The Europe Upstream Bioprocessing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Upstream Bioprocessing Market report:
The Europe Upstream Bioprocessing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Upstream Bioprocessing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Upstream Bioprocessing Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Upstream Bioprocessing Market
